Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-017738
Filing Date
2021-03-25
Accepted
2021-03-25 16:15:46
Documents
64
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_aikidopharma.htm 10-K 1018017
2 LIST OF SUBSIDIARIES f10k2020ex21-1_aikido.htm EX-21.1 2637
3 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT f10k2020ex23-1_aikido.htm EX-23.1 2073
4 CERTIFICATION f10k2020ex31-1_aikido.htm EX-31.1 14625
5 CERTIFICATION f10k2020ex32-1_aikido.htm EX-32.1 7024
12 GRAPHIC img_001.jpg GRAPHIC 7209
13 GRAPHIC img_002.jpg GRAPHIC 9017
  Complete submission text file 0001213900-21-017738.txt   3866902

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aiki-20201231.xml EX-101.INS 453510
7 XBRL SCHEMA FILE aiki-20201231.xsd EX-101.SCH 63236
8 XBRL CALCULATION FILE aiki-20201231_cal.xml EX-101.CAL 41878
9 XBRL DEFINITION FILE aiki-20201231_def.xml EX-101.DEF 167647
10 XBRL LABEL FILE aiki-20201231_lab.xml EX-101.LAB 384257
11 XBRL PRESENTATION FILE aiki-20201231_pre.xml EX-101.PRE 269961
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

EIN.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-05576 | Film No.: 21772551
SIC: 8731 Services-Commercial Physical & Biological Research